The Avastin Saga
Here is a current story that illustrates some of the major conundrums of modern drug development and health care. For those who are familiar with this little tale-in-progress, my guess is that you are,...
View ArticleLet the Death Panel Accusations Fly!
Yesterday, the Oncologic Drugs Advisory Committee issued its recommendation to the FDA on the use of Avastin for the treatment of breast cancer: no. Based on clinical trial results, ODAC members voted...
View ArticleThe Many Reasons Why Personalized Medicine Is So Tricky
The European Multidisciplinary Cancer Congress is the gift that keeps on giving. It’s with an almost predictable rhythm these days that articles either praising the promise of personalized medicine...
View ArticleClik here to view.
The Big Shortage—Where Have All the Drugs Gone?
I’d mentioned several weeks ago about wanting to dig into the reported shortage of drugs for cancer and other diseases, but have been putting it off because I had nothing more to offer beyond...
View ArticleThe Person Behind the Prescriptions
From time to time, I look at her remnants – the belts hanging in the closet, framed pictures of her with her children when they were still young, jewelry, notes in the back of old cookbooks. But it’s...
View ArticleIn the Headlines: Use Less Medicine
Just a quick post today, because I wasn’t meaning to write here today but these two headlines jumped out and screamed to be linked to. First, there’s this one, from Reuters, an impressively lengthy...
View Article
